These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 10828818)

  • 41. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-microbial and therapeutic effects of modified Burow's solution on refractory otorrhea.
    Jinnouchi O; Kuwahara T; Ishida S; Okano Y; Kasei Y; Kunitomo K; Takeda N
    Auris Nasus Larynx; 2012 Aug; 39(4):374-7. PubMed ID: 21862264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ototopic applications of povidone iodine/dexamethasone in the rat.
    Pawlowski K; Koulich E; Wright CG; Roland P
    Otol Neurotol; 2013 Jan; 34(1):167-74. PubMed ID: 23202157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moxalactam therapy. Its use in chronic suppurative otitis media and malignant external otitis.
    Haverkos HW; Caparosa R; Yu VL; Kamerer D
    Arch Otolaryngol; 1982 Jun; 108(6):329-33. PubMed ID: 6212042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ototopical agents in the treatment of the draining ear.
    Denneny JC
    Am J Manag Care; 2002 Oct; 8(14 Suppl):S353-60. PubMed ID: 12408221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The comparative study of the of clinical effectiveness of the Candibiotic, Otipax, and Anauran ear drops for the treatment of acute external and middle ear otitis].
    Kiselev AB; Chaukina VA
    Vestn Otorinolaringol; 2013; (6):76-8. PubMed ID: 24429865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa.
    Sumitsawan Y; Tharavichitkul P; Prawatmuang W; Ingsuwan B; Sriburi P
    J Med Assoc Thai; 1995 Sep; 78(9):455-9. PubMed ID: 7561571
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tuberculous otitis media developing as a complication of tympanostomy tube insertion.
    Kim CW; Jin JW; Rho YS
    Eur Arch Otorhinolaryngol; 2007 Mar; 264(3):227-30. PubMed ID: 17021778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Initial impact of the acute otitis externa clinical practice guideline on clinical care.
    Bhattacharyya N; Kepnes LJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):414-7. PubMed ID: 21531870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An economic evaluation of two ototopical treatments for acute otitis media in tympanostomy tube patients.
    Roland PS; Waycaster CR; Wall GM; Glass JD
    Value Health; 2006; 9(4):219-26. PubMed ID: 16903991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes.
    Roland PS; Anon JB; Moe RD; Conroy PJ; Wall GM; Dupre SJ; Krueger KA; Potts S; Hogg G; Stroman DW
    Laryngoscope; 2003 Dec; 113(12):2116-22. PubMed ID: 14660913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic suppurative otitis media: antimicrobial therapy or surgery?
    Bluestone CD; Kenna MA
    Pediatr Ann; 1984 May; 13(5):417-21. PubMed ID: 6739180
    [No Abstract]   [Full Text] [Related]  

  • 53. [Topical treatment of otorrheas. Risks and indications].
    Morera C; Vila B
    An Otorrinolaringol Ibero Am; 1987; 14(5):541-62. PubMed ID: 3674340
    [No Abstract]   [Full Text] [Related]  

  • 54. Medical management of chronic suppurative otitis media without cholesteatoma in children.
    Kenna MA; Bluestone CD; Reilly JS; Lusk RP
    Laryngoscope; 1986 Feb; 96(2):146-51. PubMed ID: 3945144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of Burow's solution as an ear drop on Intractable chronic suppurative diseases of the external ear canal and middle ear].
    Terayama Y; Takizawa M; Gotouda H; Sutou S; Kashiwamura M
    Nihon Jibiinkoka Gakkai Kaiho; 2003 Jan; 106(1):28-33. PubMed ID: 12647321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical fluoroquinolones for eye and ear.
    Morden NE; Berke EM
    Am Fam Physician; 2000 Oct; 62(8):1870-6. PubMed ID: 11057842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ofloxacin otic solution: a review of its use in the management of ear infections.
    Simpson KL; Markham A
    Drugs; 1999 Sep; 58(3):509-31. PubMed ID: 10493278
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative therapeutic considerations in chronic suppurative otitis media.
    Papastavros T; Giamarellou H; Varlejides S
    Laryngoscope; 1989 Jun; 99(6 Pt 1):655-9. PubMed ID: 2725163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial therapy for chronic suppurative otitis media.
    Fairbanks DN
    Ann Otol Rhinol Laryngol Suppl; 1981; 90(3 Pt 3):58-62. PubMed ID: 6791565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
    Al-Shawwa BA; Wegner D
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.